\-\ Texto\\:\\ \ \(0\)\
\-\ absent\\ knee\\ jerk\\ reflex\\.\ \(0\)\
\-\ leg\\ strength\\ only\\ 2\\/5\\.\ \(0\)\
\-\ steroids\\.\ \(34\)\
\-\ follow\\ up\\ mri\\ three\\ months\\ later\\ demonstrated\\ the\\ lesion\\'s\\ stability\\.\ \(0\)\
\-\ mixed\\ signal\\ intensity\\ expansile\\ lesion\\ t9\\ and\\ t10\\.\ \(0\)\
\-\ low\\ signal\\ intensity\\ rim\\ with\\ high\\ signal\\ intensity\\ central\\ nidus\\.\ \(0\)\
\-\ minimal\\ enhancement\\ following\\ contrast\\ administration\\.\ \(0\)\
\-\ cavernous\\ malformation\\,\\ \\ thoracic\\ spinal\\ cord\ \(0\)\
\-\ \\â\\€\\¢\\ astrocytoma\ \(1\)\
\-\ \\â\\€\\¢\\ ependymoma\ \(8\)\
\-\ \\â\\€\\¢\\ hemangioblastoma\ \(1\)\
\-\ \\â\\€\\¢\\ vascular\\ malformation\ \(1\)\
\-\ 53\\ year\\ old\\ female\\ with\\ sudden\\ onset\\ of\\ bilateral\\ leg\\ weakness\\ and\\ numbness\ \(1\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ intensity\\:\\ 0\\.11879502601458851\ \(0\)\
\-\ jerk\\:\\ 0\\.09524646234418727\ \(0\)\
\-\ malformation\\:\\ 0\\.08739350391041999\ \(0\)\
\-\ signal\\:\\ 0\\.0866567050104915\ \(0\)\
\-\ leg\\:\\ 0\\.08615890534894351\ \(0\)\
\-\ 2\\/5\\:\\ 0\\.08116168941254484\ \(0\)\
\-\ \\â\\€\\¢\\:\\ 0\\.08035971033825065\ \(0\)\
\-\ t9\\:\\ 0\\.0791853986455287\ \(0\)\
\-\ t10\\:\\ 0\\.0791853986455287\ \(0\)\
\-\ nidus\\:\\ 0\\.07124899853775661\ \(0\)\
\-\ stability\\:\\ 0\\.061185476360666\ \(0\)\
\-\ hemangioblastoma\\:\\ 0\\.06052787002236407\ \(0\)\
\-\ reflex\\:\\ 0\\.05970045308470289\ \(0\)\
\-\ 53\\:\\ 0\\.059113151340711954\ \(0\)\
\-\ expansile\\:\\ 0\\.053724943726695215\ \(0\)\
\-\ numbness\\:\\ 0\\.05264087464941236\ \(0\)\
\-\ steroids\\:\\ 0\\.05153497279961227\ \(0\)\
\-\ cavernous\\:\\ 0\\.050813950769831806\ \(0\)\
\-\ sudden\\:\\ 0\\.050615179147575844\ \(0\)\
\-\ ependymoma\\:\\ 0\\.04903956201522772\ \(0\)\
\-\ strength\\:\\ 0\\.04861074234769515\ \(0\)\
\-\ mixed\\:\\ 0\\.04811440244794271\ \(0\)\
\-\ absent\\:\\ 0\\.047481161994999424\ \(0\)\
\-\ rim\\:\\ 0\\.04637206913718811\ \(0\)\
\-\ administration\\:\\ 0\\.045482823909015\ \(0\)\
\-\ lesion\\:\\ 0\\.044629621179498834\ \(0\)\
\-\ minimal\\:\\ 0\\.04313435859488202\ \(0\)\
\-\ astrocytoma\\:\\ 0\\.042542951265042254\ \(0\)\
\-\ thoracic\\:\\ 0\\.04223150648851605\ \(0\)\
\-\ cord\\:\\ 0\\.04163043487442822\ \(0\)\
\-\ weakness\\:\\ 0\\.04068732503882544\ \(0\)\
\-\ knee\\:\\ 0\\.03972424003282406\ \(0\)\
\-\ later\\:\\ 0\\.03955664924349902\ \(0\)\
\-\ spinal\\:\\ 0\\.03922790013307161\ \(0\)\
\-\ three\\:\\ 0\\.036931079850601414\ \(0\)\
\-\ central\\:\\ 0\\.03604655585717896\ \(0\)\
\-\ vascular\\:\\ 0\\.03592055471697047\ \(0\)\
\-\ follow\\:\\ 0\\.034810249640338894\ \(0\)\
\-\ onset\\:\\ 0\\.034582323409296796\ \(0\)\
\-\ only\\:\\ 0\\.03294117510878122\ \(0\)\
\-\ demonstrated\\:\\ 0\\.03214641003149958\ \(0\)\
\-\ following\\:\\ 0\\.031093304575655747\ \(0\)\
\-\ low\\:\\ 0\\.03046369298546666\ \(0\)\
\-\ high\\:\\ 0\\.02998135975739507\ \(0\)\
\-\ months\\:\\ 0\\.0299223242908983\ \(0\)\
\-\ up\\:\\ 0\\.02945957885966953\ \(0\)\
\-\ enhancement\\:\\ 0\\.029365240591320972\ \(0\)\
\-\ bilateral\\:\\ 0\\.026587406786082613\ \(0\)\
\-\ mri\\:\\ 0\\.02517020326813615\ \(0\)\
\-\ contrast\\:\\ 0\\.024522765215485964\ \(0\)\
\-\ \\'s\\:\\ 0\\.024154443825218527\ \(0\)\
\-\ female\\:\\ 0\\.02252256758266453\ \(0\)\
\-\ year\\:\\ 0\\.012257759862473265\ \(0\)\
\-\ old\\:\\ 0\\.011217110216182751\ \(0\)\
\-\ and\\:\\ 0\\.004615615531595345\ \(0\)\
\-\ \\,\\:\\ 0\\.003470641865606248\ \(0\)\
\-\ \\.\\:\\ 0\\.003185855803607999\ \(0\)\
\-\ with\\:\\ 0\\.003000107079227942\ \(0\)\
\-\ the\\:\\ 0\\.0017724267269695615\ \(0\)\
\-\ of\\:\\ 0\\.0014936384717690824\ \(0\)\
